PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsprader-willi syndrome
MeSH D011218 - prader-willi syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008607:Intellectual disability
$
Success rate
D000015:Multiple abnormalities
0 Companies
0 Drugs
Success rate
D025063:Chromosome disorders
0 Companies
0 Drugs
Success rate
D009765:Obesity
D000096803:Imprinting disorders
0 Companies
0 Drugs
Success rate
D011218: 
Prader-willi syndrome
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
BioPartnersSomatropin Somatropin Biopartners  2013-08-05   
Somatropin Valtropin  2006-04-24   
Eli LillySomatropin Humatrope  1986-10-16   
EMD SeronoSomatropin Saizen  1996-10-08   
Somatropin Serostim  1996-08-23   
Emergent BiosolutionsSomatropin Accretropin  2008-01-23   
Ferring PharmaceuticalsSomatropin Zomacton  1995-05-25   
GenentechSomatropin Nutropin  1993-11-17   
IpsenSomatropin NutropinAq  2001-02-15   
Novo NordiskSomatropin Norditropin  2000-06-20   
Pharmacia & UpjohnSomatropin Genotropin  1995-08-24   
SandozSomatropin Omnitrope  2006-04-12   
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
33%
3/9
Phase 3
43%
3/7
Approved: 2Overall Success rate: 14%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
BioPartners
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use